Nalaganje...
Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study
BACKGROUND: This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency. METHODS: This post hoc analysis evaluated data from non‐frail patients with...
Shranjeno v:
| izdano v: | J Diabetes |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley Publishing Asia Pty Ltd
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899823/ https://ncbi.nlm.nih.gov/pubmed/31094074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1753-0407.12952 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|